Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

CardioGenics Holdings Inc

Healthcare US CGNH

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0002
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00961M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.75355M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Type yearly yearly yearly yearly yearly
Date 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Income before tax -1.91632M -2.67988M -2.93694M -1.31969M -3.93517M
Minority interest 0.00000M 0.00000M -0.35622M -0.33793M -
Net income -1.91632M -2.67988M -2.91865M -1.30805M -3.87438M
Selling general administrative 0.54M 0.45M 1.89M 0.74M 1.35M
Selling and marketing expenses - - - - -
Gross profit 0.00000M 0.00000M 0.00000M 0.00130M 0.00888M
Reconciled depreciation - - - - -
Ebit -0.10371M -1.10851M -2.32780M -1.28282M -3.58705M
Ebitda -0.08894M -1.08741M -2.30603M -1.25763M -3.56144M
Depreciation and amortization 0.01M 0.02M 0.02M 0.03M 0.03M
Non operating income net other 0.00000M 0.00000M 0.00000M 0.00000M -
Operating income -0.77214M -0.97351M -2.52680M -1.31371M -3.78888M
Other operating expenses 0.77M 0.97M 2.33M 1.29M 3.74M
Interest expense 0.00000M 0.00000M 0.30M 0.02M 0.02M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items 0.00000M 0.00000M 0.00000M 0.00000M -
Non recurring 0.00000M 0.00000M 0.00000M 0.00000M -
Other items 0.00000M 0.00000M 0.00000M 0.00000M -
Income tax expense 1.14M 1.71M 0.28M 0.02M 0.14M
Total revenue 0.00000M 0.00000M 0.00000M 0.00130M 0.00888M
Total operating expenses 0.77M 0.97M 2.33M 1.29M 3.74M
Cost of revenue 0.00000M 0.00000M 0.00000M 0.00000M 3.83M
Total other income expense net -0.66844M 0.14M -0.30902M -0.00598M -0.14629M
Discontinued operations 0.00000M 0.00000M 0.00000M 0.00000M -
Net income from continuing ops -1.91632M -2.67988M -2.93694M -1.31646M -
Net income applicable to common shares -1.91632M -2.67988M -2.91865M -1.30805M -
Preferred stock and other adjustments 0.00000M 0.00000M 0.00000M 0.00000M -
Breakdown 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Type yearly yearly yearly yearly yearly
Date 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Total assets 0.23M 0.27M 0.55M 0.38M 2.85M
Intangible assets 0.10M 0.11M 0.12M 0.11M 0.13M
Earning assets - - - - -
Other current assets 0.00000M 0.00000M 0.00000M 0.00000M 0.05M
Total liab 1.79M 1.42M 1.46M 0.89M 0.45M
Total stockholder equity -1.56299M -1.15506M -0.56082M -0.16882M 2.73M
Deferred long term liab 0.00000M 0.00000M 0.00000M 0.00000M -
Other current liab 1.54M 1.06M 0.10M 0.74M 0.31M
Common stock 0.00114M 0.00069M 0.00056M 0.00054M 0.00054M
Capital stock - - - - -
Retained earnings -49.55407M -47.63775M -44.95787M -42.03922M -38.88093M
Other liab 0.00000M 0.00000M 0.00000M 0.00000M -
Good will 0.00000M 0.00000M 0.00000M 0.00000M -
Other assets 0.04M 0.05M 0.05M 0.00000M -
Cash 0.05M 0.07M 0.31M 0.03M 0.67M
Cash and equivalents - - - - -
Total current liabilities 1.79M 1.42M 1.16M 0.89M 0.44M
Current deferred revenue 1.20M 0.86M - 0.74M 0.31M
Net debt 0.02M 0.00119M 0.00280M -0.02438M -0.64086M
Short term debt 0.07M 0.07M 0.01M 0.00263M 0.03M
Short long term debt 0.00000M 0.00000M 0.00000M 0.00000M -
Short long term debt total 0.07M 0.07M 0.32M 0.00263M 0.03M
Other stockholder equity 47.84M 46.51M 44.51M 42.04M 41.77M
Property plant equipment 0.04M 0.04M 0.05M 0.07M 0.08M
Total current assets 0.05M 0.07M 0.38M 0.20M 2.07M
Long term investments 0.00000M 0.00000M 0.00000M 0.00000M -
Net tangible assets -1.66593M -1.26319M -0.67925M -0.27885M -
Short term investments 0.00000M 0.00000M 0.00000M 0.05M -
Net receivables 0.00238M 0.00285M 0.06M 0.13M 0.04M
Long term debt 0.00000M 0.00000M 0.30M 0.00000M 0.00300M
Inventory 0.00000M 0.00000M 0.00000M 0.00000M -
Accounts payable 0.18M 0.29M 1.05M 0.15M 0.10M
Total permanent equity 0.00000M 0.00000M 0.00000M 0.00000M -
Noncontrolling interest in consolidated entity 0.00000M 0.00000M 0.00000M 0.00000M -
Temporary equity redeemable noncontrolling interests 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated other comprehensive income 0.15M -0.02396M -0.11751M -0.16664M -0.16676M
Additional paid in capital 0.00000M 0.00000M 0.00000M 0.00000M -
Common stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Preferred stock total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Retained earnings total equity 0.00000M 0.00000M 0.00000M 0.00000M -
Treasury stock 0.00000M 0.00000M 0.00000M 0.00000M -
Accumulated amortization 0.00000M 0.00000M 0.00000M 0.00000M -
Non currrent assets other 0.04M 0.05M 0.00000M 0.00000M 0.57M
Deferred long term asset charges 0.00000M 0.00000M 0.00000M 0.00000M -
Non current assets total 0.18M 0.20M 0.17M 0.18M 0.78M
Capital lease obligations 0.00000M 0.00000M 0.00000M 0.00000M -
Long term debt total 0.00000M 0.00000M 0.00000M 0.00000M -
Breakdown 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Type yearly yearly yearly yearly yearly
Date 2015-10-31 2014-10-31 2013-10-31 2012-10-31 2011-10-31
Investments 0.00000M 0.00000M 0.00000M 0.00000M -
Change to liabilities 0.22M 0.18M 0.42M 0.19M 0.07M
Total cashflows from investing activities -0.00206M -0.00206M -0.01584M -0.00803M -
Net borrowings 0.32M 0.35M 0.83M 0.07M -
Total cash from financing activities 0.36M 0.40M 0.93M 0.34M 0.32M
Change to operating activities 0.00402M 0.06M 0.02M 0.11M -
Net income -1.91632M -2.67988M -2.93694M -1.31646M -3.89975M
Change in cash -0.02080M -0.19243M 0.24M -0.64219M -1.17555M
Begin period cash flow 0.07M 0.26M 0.03M 0.67M 1.84M
End period cash flow 0.05M 0.07M 0.26M 0.03M 0.67M
Total cash from operating activities -0.60664M -0.59711M -0.71855M -0.97084M -1.40901M
Issuance of capital stock - - - - -
Depreciation 0.01M 0.02M 0.02M 0.03M 0.03M
Other cashflows from investing activities 0.00000M 0.00000M 0.00000M 0.00000M -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory 0.00000M 0.00000M 0.00000M 0.00000M -
Change to account receivables 0.00023M 0.00002M 0.00019M 0.00856M -0.00900M
Sale purchase of stock 0.00000M 0.00000M 0.00000M 0.00000M -
Other cashflows from financing activities 0.33M 0.35M 0.83M 0.10M -0.01700M
Change to netincome 1.07M 1.20M 1.59M 0.02M -
Capital expenditures 0.00206M 0.00000M 0.02M 0.00803M 0.03M
Change receivables 0.00000M 0.00000M 0.00000M 0.00000M -
Cash flows other operating 0.00000M 0.00000M 0.00000M 0.00000M -
Exchange rate changes 0.00000M 0.00000M 0.00000M 0.00000M -
Cash and cash equivalents changes 0.00000M 0.00000M 0.00000M 0.00000M -
Change in working capital 0.23M 0.25M 0.48M 0.30M 0.30M
Stock based compensation - - - - -
Other non cash items 1.07M 1.81M 1.72M 0.02M 2.17M
Free cash flow -0.60870M -0.59711M -0.73439M -0.97887M -1.44202M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CGNH
CardioGenics Holdings Inc		 - -% 0.0001 - - 80069.43 - 50421.43 -3.0516
TMO
Thermo Fisher Scientific Inc		 -0.6 0.13% 464.01 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 1.02 0.58% 178.19 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 -0.57 0.45% 126.49 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -16.36 2.91% 545.73 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories' immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was incorporated in 1997 and is based in Mississauga, Canada.

CardioGenics Holdings Inc

6295 Northam Drive, Mississauga, ON, Canada, L4V 1W8

Key Executives

Name Title Year Born
Dr. Yahia Abdul Gawad Founder, CEO & Director 1958
Mr. James A. Essex CA, MBA Chief Financial Officer 1949
Ms. Linda J. Sterling F.Inst.L.C.O. Corp. Sec. & Director 1961
Ms. Linda J. Sterling F.Inst.L.C.O. Corporate Secretary & Director 1961
Dr. Yahia Abdul Gawad Ch.B., M.D., MB, MSc. Founder, CEO & Director 1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.